IL22 and myeloid sarcoma: In conclusion, we found that IL-1R1 is associated with a reduction in ILC3 cells in the small intestine, which may result in reduced IL-22 expression, leading to a worsening of obesity and MS due to increased intestinal permeability and bacterial translocation to the VAT.